97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04064697 (ClinicalTrials.gov)	April 22, 2021	20/8/2019	Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring ...	Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative ...	Ulcerative Colitis, Unspecified	Drug: Valganciclovir	Centre Hospitalier Universitaire de Saint Etienne	Ministry of Health, France	Recruiting	18 Years	N/A	All	120	Phase 3	France
2	EUCTR2019-001032-54-FR (EUCTR)	23/07/2019	19/06/2019	Impact of anti-cytomegalovirus (valganciclovir) treatment in the management of relapsing ulcerative ...	Impact of anti-cytomegalovirus (valganciclovir) treatment in the management of relapsing ulcerative ...	Patient with active ulcerative colitis who failed to anti-TNF with endoscopic active disease with an ...	Trade Name: valganciclovir Product Name: valganciclovir Trade Name: vedolizumab Product Name: vedolizum ...	CHU de Saint Etienne	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France

First Previous1Next Last